Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3
This study uses a newly published, evidence-based conceptual model to study the determinants of implementation success, implementation outcomes, and health care outcomes resulting from implementing an asthma portal, MyAsthma, in the national, Agency for Health Care Research and Quality(AHRQ)-funded, Center for Pediatric Practice Research and Learning. Technically, the portal will be implemented with 2 innovative approaches that facilitate rapid cycle evaluation in multiple Electronic Health Records (EHRs). Although many patient portals are simple vehicles for transferring information about upcoming appointments, test results or laboratory findings, the asthma portal in this project extends this basic functionality to provide asthma education, collect patient-reported outcomes, evaluate medication use and side effects, and track parents' preferences and goals. Because asthma is an AHRQ priority condition which addresses three AHRQ priority criteria (children, low income, and special health care needs), our study will use this population to focus on stage 3 Meaningful Use (MU3) objectives. It is the hope that by conducting this study, translational knowledge will be gained to make recommendations for practice implementation and actionable policy statements.
|Study Design:||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3|
- Use of the MyAsthma Portal Survey [ Time Frame: Each subject will contribute data up to 3 times over a 3 month period ] [ Designated as safety issue: No ]We will evaluate adoption of the MyAsthma portal by determining which subjects completed the MyAsthma Portal Survey at least once during the study period. We will also measure sustained use of the portal, defined as completion of the MyAsthma Portal Survey more than once during the study period.
- Asthma management [ Time Frame: 2 weeks following completion of a MyAsthma portal survey ] [ Designated as safety issue: No ]We will measure those making an asthma office visit in the two weeks following completion of a MyAsthma portal survey. We will also measure the number of subjects that refill their asthma medication or make a medication change in the two weeks following completion of a MyAsthma portal survey.
|Study Start Date:||October 2013|
|Estimated Study Completion Date:||September 2015|
|Estimated Primary Completion Date:||September 2015 (Final data collection date for primary outcome measure)|
Experimental: MyAsthma Web Portal
The portal, MyAsthma, will provide asthma education, collect patient-reported outcomes, evaluate medication use and side effects, and track parents' concerns and goals. Parents will log into the web portal each month, and the information entered by parents will be shared through the electronic health record with the child's primary care provider.
|Other: MyAsthma Web Portal|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01966068
|Contact: Alexander Fiks, MD, MSCEfirstname.lastname@example.org|
|Contact: Stacia Finchemail@example.com|
|United States, Illinois|
|Elk Grove Village, Illinois, United States, 60007|
|Contact: Stacia Finch 847-434-7629 SFinch@aap.org|
|United States, Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19104|
|Contact: Alex G Fiks, MD, MSCE 267-426-2304 firstname.lastname@example.org|
|Principal Investigator:||Alexander Fiks, MD, MSCE||Children's Hospital of Philadelphia|